Dr. Herbert Loong
herbloongmd.bsky.social
Medical Oncologist w/ interests in #lungcancer, #sarcoma & #drugdevelopment | Associate Professor, Department of Clinical Oncology & Medical Director (Oncology), Phase 1 Clinical Trials Centre, CUHK
👤 Joined on 15 November 2024
230
Followers
217
Following
50
Total Posts
📜 Kullanıcı Geçmişi
- 15 Kas 2024, 18:54
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@herbloongmd.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Excited to be in Singapore for @ascocancer.bsky.social Breakthrough with @herbloongmd.bsky.social Naoto Ueno, Beth Mittendorf, and Rebecca Dent!
Show Post
🫁 ASCO AI: Data presented at ASCO 2026 highlight how #AI-enabled workflows can improve lung cancer screening. Results included: ✅ Higher lung cancer screening uptake ✅ More stage I diagnoses ✅ Fewer late-stage presentations Explore the findings ➡️ https://ow.ly/EuzT50Z7ZJu
Show PostEnhancing cost-effectiveness considerations in the adoption of new drugs in Hong Kong www.hkmj.org/abstracts/v3...
Show Post
ASCO Breakthrough has been gaining momentum since its inception in Thailand back in 2019. Hear from Dr. Tony S. K. Mok on how this vital conference has evolved and what's in store for #ASCOBT26 in Singapore. Register today: https://bit.ly/4e1aydd
Show Post
During #CIM, SITC celebrates life-saving IO advances that improve the outcomes of patients worldwide. On June 16, join experts for our free CME ACI: Toxicity Management program & optimize care for high-risk patients. Register: https://ow.ly/vKIf50Z8Q5L #CancerImmunotherapyMonth #cancer
Show Post